Zhang L, Chi B, Chai J, Qin L, Zhang G, Hua P, Jin C. LncRNA CCDC144NL-AS1 serves as a prognosis biomarker for non-small cell lung cancer and promotes cellular function by targeting miR-490-3p. Mol Biotechnol. 2021;63(10):933–40.

Article  CAS  PubMed  Google Scholar 

Chen Y, Zitello E, Guo R, Deng Y. The function of LncRNAs and their role in the prediction, diagnosis, and prognosis of lung cancer. Clin Transl Med. 2021;11(4):e367.

Le P, Romano G, Nana-Sinkam P, Acunzo M. Non-coding RNAs in cancer diagnosis and therapy: focus on lung cancer. Cancers. 2021;13(6):1372.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ku GW, Kang Y, Yu S-L, Park J, Park S, Jeong IB, et al. LncRNA LINC00240 suppresses invasion and migration in non-small cell lung cancer by sponging miR-7-5p. BMC Cancer. 2021;21:1–13.

Article  Google Scholar 

Saleh AA, Elghobashy YA, Kasemy ZA, Hegazy A, ALrefai AA. Impact of dysregulated LINC01559 and LINC01410 expression on the diagnosis and survival of non-small cell lung cancer. Biochem Genet. 2024;62(5):4011–4026. https://doi.org/10.1007/s10528-023-10632-1.

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2018;68(6):394–424.

Article  Google Scholar 

Malhotra J, Malvezzi M, Negri E, La Vecchia C, Boffetta P. Risk factors for lung cancer worldwide. Eur Respir J. 2016;48(3):889–902.

Article  PubMed  Google Scholar 

Wang BY, Huang JY, Chen HC, Lin CH, Lin SH, Hung WH, Cheng YF. The comparison between adenocarcinoma and squamous cell carcinoma in lung cancer patients. J Cancer Res Clin Oncol. 2020;146(1):43–52. https://doi.org/10.1007/s00432-019-03079-8.

Article  PubMed  Google Scholar 

Zarogoulidis K, Zarogoulidis P, Darwiche K, Boutsikou E, Machairiotis N, Tsakiridis K, et al. Treatment of non-small cell lung cancer (NSCLC). J Thorac Dis. 2013;5(Suppl 4):S389–96. https://doi.org/10.3978/j.issn.2072-1439.2013.07.10.

Article  PubMed  PubMed Central  Google Scholar 

Chetan MR, Gleeson FV. Radiomics in predicting treatment response in non-small-cell lung cancer: current status, challenges and future perspectives. Eur Radiol. 2021;31:1049–58.

Article  PubMed  Google Scholar 

Shukla S, Evans JR, Malik R, Feng FY, Dhanasekaran SM, Cao X, et al. Development of a RNA-Seq based Prognostic signature in Lung Adenocarcinoma. J Natl Cancer Inst. 2017;109(1). https://doi.org/10.1093/jnci/djw200.

Lin T, Fu Y, Zhang X, Gu J, Ma X, Miao R, et al. A seven-long noncoding RNA signature predicts overall survival for patients with early stage non-small cell lung cancer. Aging. 2018;10(9):2356–66. https://doi.org/10.18632/aging.101550.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tajmehri H, Mousavi FS, Golrokh FJ, Nezami PV, Khanpour P, Noroudi SG, Salehzadeh A. Evaluation of the cytotoxic effect of cobalt oxide nanoparticles functionalized by glucose and conjugated with lapatinib (Co3O4@ Glu-Lapatinib) on a lung cancer cell line and evaluation of the expression of CASP8, mTOR1, and MAPK1 genes. BioNanoScience. 2024;14:999–1010. https://doi.org/10.1007/s12668-024-01348-6.

Article  Google Scholar 

Tariq M, Hussain N, Rehman K, Akash MSH, Al Haddad AHI, Said ASA, et al. Macrophages M2 polarization is involved in lapatinib-mediated chemopreventive effects in the lung cancer. Biomed Pharmacother. 2023;161:114527. https://doi.org/10.1016/j.biopha.2023.114527.

Article  CAS  PubMed  Google Scholar 

Tang L, Li J, Zhao Q, Pan T, Zhong H, Wang W. Advanced and innovative nano-systems for anticancer targeted drug delivery. Pharmaceutics. 2021;13(8):1151.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kashkooli FM, Soltani M, Souri M. Controlled anti-cancer drug release through advanced nano-drug delivery systems: static and dynamic targeting strategies. J Controlled Release. 2020;327:316–49.

Article  Google Scholar 

Zeinali M, Abbaspour-Ravasjani S, Ghorbani M, Babazadeh A, Soltanfam T, Santos AC, et al. Nanovehicles for co-delivery of anticancer agents. Drug Discov Today. 2020;25(8):1416–30.

Liu J, Bai Y, Li Y, Li X, Luo K. Reprogramming the immunosuppressive tumor microenvironment through nanomedicine: an immunometabolism perspective. eBioMedicine. 2024;107. https://doi.org/10.1016/j.ebiom.2024.105301.

Samtani MN, Sheehan JJ, Fu DJ, Remmerie B, Sliwa JK, Alphs L. Management of antipsychotic treatment discontinuation and interruptions using model-based simulations. Clin Pharmacol. 2012;4:25–40. https://doi.org/10.2147/cpaa.S32735.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li H, Gong Q, Luo K. Biomarker-driven molecular imaging probes in radiotherapy. Theranostics. 2024;14(10):4127–46. https://doi.org/10.7150/thno.97768.

Article  PubMed  PubMed Central  Google Scholar 

Ghosh P, Han G, De M, Kim CK, Rotello VM. Gold nanoparticles in delivery applications. Adv Drug Deliv Rev. 2008;60(11):1307–15. https://doi.org/10.1016/j.addr.2008.03.016.

Article  CAS  PubMed  Google Scholar 

Alkilany AM, Murphy CJ. Toxicity and cellular uptake of gold nanoparticles: what we have learned so far? J Nanopart Res. 2010;12(7):2313–33. https://doi.org/10.1007/s11051-010-9911-8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jacob J, Haponiuk JT, Thomas S, Gopi S. Biopolymer based nanomaterials in drug delivery systems: a review. Mater Today Chem. 2018;9:43–55.

Article  CAS  Google Scholar 

Park S-B, Lih E, Park K-S, Joung YK, Han DK. Biopolymer-based functional composites for medical applications. Prog Polym Sci. 2017;68:77–105.

Article  CAS  Google Scholar 

Jhaveri J, Raichura Z, Khan T, Momin M, Omri A. Chitosan nanoparticles-insight into Properties, Functionalization and Applications in Drug Delivery and Theranostics. Molecules. 2021;26(2):272.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zarepour A, Egil AC, Cokol Cakmak M, Esmaeili Rad M, Cetin Y, Aydinlik S, et al. Fabrication of a dual-drug-loaded smart Niosome-g-Chitosan Polymeric platform for Lung Cancer Treatment. Polymers. 2023;15(2):298.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aranaz I, Alcántara AR, Civera MC, Arias C, Elorza B, Heras Caballero A, Acosta N. Chitosan: an overview of its properties and applications. Polymers. 2021;13(19):3256.

Article  CAS  PubMed  PubMed Central  Google Scholar 

da Silva AB, Rufato KB, de Oliveira AC, Souza PR, da Silva EP, Muniz EC, et al. Composite materials based on chitosan/gold nanoparticles: from synthesis to biomedical applications. Int J Biol Macromol. 2020;161:977–98. https://doi.org/10.1016/j.ijbiomac.2020.06.113.

Article  CAS  PubMed  Google Scholar 

Shade CW. Liposomes as Advanced Delivery systems for Nutraceuticals. Integr Med (Encinitas). 2016;15(1):33–6.

PubMed  Google Scholar 

Dananjaya SHS, Udayangani RMC, Oh C, Nikapitiya C, Lee J, De Zoysa M. Green synthesis, physio-chemical characterization and anti-candidal function of a biocompatible chitosan gold nanocomposite as a promising antifungal therapeutic agent. RSC Adv. 2017;7(15):9182–93. https://doi.org/10.1039/C6RA26915J.

Article  CAS  Google Scholar 

Sun L, Pu S, Li J, Cai J, Zhou B, Ren G, et al. Size controllable one step synthesis of gold nanoparticles using carboxymethyl chitosan. Int J Biol Macromol. 2019;122:770–83. https://doi.org/10.1016/j.ijbiomac.2018.11.006.

Article  CAS  PubMed  Google Scholar 

Leiva A, Bonardd S, Pino M, Saldías C, Kortaberria G, Radić D. Improving the performance of chitosan in the synthesis and stabilization of gold nanoparticles. Eur Polymer J. 2015;68:419–31. https://doi.org/10.1016/j.eurpolymj.2015.04.032.

Article  CAS  Google Scholar 

Shamsi H, Yari R, Salehzadeh A. Biosynthesized BiFe2O4@ Ag nanoparticles mediated Scenedesmus obliquus induce apoptosis in AGS gastric cancer cell line. Sci Rep. 2024;14(1):10284.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bakhsh MR, Rouhi L, Ghaedi K, Hashemi M, Peymani M, Samarghandian S. Therapeutic effects of guanidine hydrochloride on breast cancer through targeting KCNG1 gene. Biomed Pharmacother. 2023;164:114982.

Article  CAS  PubMed